Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers

This study has been completed.
Information provided by (Responsible Party):
MOstergaard, Glostrup University Hospital, Copenhagen Identifier:
First received: December 9, 2009
Last updated: August 18, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2013
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)